Nick Conley

What if we embrace bacteria as agents of health and survival rather than agents of disease?

Apply to Attend TEDMED 2018
Join us in Palm Springs, CA at The La
Quinta Resort and Club, this Nov 14 - 16, 2018.
Apply Today!

Have a suggestion for The Hive?
Submit a Nomination Today

Share This Talk

About Nick Conley

Nick Conley is Co-Founder and CEO of EpiBiome. He completed a PhD in Chemistry and a postdoctoral fellowship in Developmental Biology at Stanford University. In addition to working at Stanford University with Professor W. E. Moerner, winner of the 2014 Nobel Prize in Chemistry, Nick was a Beckman Fellow, a National Science Foundation Graduate Research Fellow, a Lieberman Fellow, a Stanford Molecular Imaging Scholars Fellow, and a Younger Fellow. He has published 18 peer-reviewed journal articles and he holds 4 US patents. Prior to co-founding EpiBiome, Nick was a Research Staff Member at HGST, a Western Digital Company. He has also co-founded several successful companies in the oral and skincare space.

About This Idea

EpiBiome is a venture-backed precision microbiome engineering company working to curb the growing threat of multi-drug-resistant "superbugs" by eliminating the use of shared-class antibiotics (those shared between humans and animals) from agriculture. Instead of antibiotics, the company deploys bacteria-specific viruses that are abundant in nature and harmless to humans to treat bacterial infections. The company has garnered numerous awards and accolades, including: acceptance into the inaugural class of Illumina Accelerator; winning Johnson & Johnson’s Quick Fire Challenge; acceptance into Springboard Accelerator; winning a Bill & Melinda Gates Foundation Grand Challenges Explorations Grant; advancing from 480 companies to the final 3 in the SXSW Accelerator at the Interactive Festival; admission into StartX, Stanford’s stage-agnostic accelerator; and, most recently, winning BIO’s “Buzz of BIO” in the “Technologies of Tomorrow” category.

Other Hive Talks